JASPER THERAPEUTICS INC - COM (JSPR)

CUSIP: 471871103

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / COM
Total 13F shares
70,623,755
Share change
-12,091,369
Total reported value
$55,181,390
Put/Call ratio
0%
Price per share
$0.79
Number of holders
35
Value change
-$7,782,903
Number of buys
16
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 471871103?
CUSIP 471871103 identifies JSPR - JASPER THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of JASPER THERAPEUTICS INC - COM (JSPR) as of Q4 2023

As of 31 Dec 2023, JASPER THERAPEUTICS INC - COM (JSPR) was held by 35 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 70,623,755 shares. The largest 10 holders included Velan Capital Investment Management LP, Soleus Capital Management, L.P., Carlyle Group Inc., Qiming U.S. Ventures Management, LLC, Octagon Capital Advisors LP, VANGUARD GROUP INC, Opaleye Management Inc., KINGDON CAPITAL MANAGEMENT, L.L.C., BANK OF AMERICA CORP /DE/, and Nantahala Capital Management, LLC. This page lists 35 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.